awards grant
- A Phase Ib trial of tazemetostat plus mosuntezumab in untreated follicular lymphoma
- Characterizing the role of BCL10 somatic mutations in B cell lymphomas
- Elucidating the role of follicular dendritic cells in EZH2-mutated follicular lymphoma
- Epigenetic basis and therapeutic interdiction of FL progression
- Inhibiting EZH2 to Improve Immunotherapies in B-Cell Lymphomas
- Investigating the role of TOX as oncosuppressor in NFKB-driven Diffuse Large B-cell lymphomas
- Lymphoma Scientific Research Mentoring Program (LSRMP)
- Precision epigenetic therapy for SETD2+/- B cell lymphomas
- The role of SPEN and NOTCH2 mutations in pathogenesis of DLBCL.